Baltschukat, S., Schacher Engstler, B., Huang, A., Hao, H.-X., Tam, A., Wang, H. Q., … Tiedt, R. (2019). Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation. Clinical Cancer Research, clincanres.2814.2018. doi:10.1158/1078-0432.ccr-18-2814
